These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28724616)

  • 1. Marburg virus survivor immune responses are Th1 skewed with limited neutralizing antibody responses.
    Stonier SW; Herbert AS; Kuehne AI; Sobarzo A; Habibulin P; Dahan CVA; James RM; Egesa M; Cose S; Lutwama JJ; Lobel L; Dye JM
    J Exp Med; 2017 Sep; 214(9):2563-2572. PubMed ID: 28724616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
    Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
    Front Immunol; 2021; 12():703986. PubMed ID: 34484200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model.
    Keshwara R; Hagen KR; Abreu-Mota T; Papaneri AB; Liu D; Wirblich C; Johnson RF; Schnell MJ
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies.
    Ilinykh PA; Huang K; Santos RI; Gilchuk P; Gunn BM; Karim MM; Liang J; Fouch ME; Davidson E; Parekh DV; Kimble JB; Pietzsch CA; Meyer M; Kuzmina NA; Zeitlin L; Saphire EO; Alter G; Crowe JE; Bukreyev A
    Cell Host Microbe; 2020 Jun; 27(6):976-991.e11. PubMed ID: 32320678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses.
    Natesan M; Jensen SM; Keasey SL; Kamata T; Kuehne AI; Stonier SW; Lutwama JJ; Lobel L; Dye JM; Ulrich RG
    Clin Vaccine Immunol; 2016 Aug; 23(8):717-24. PubMed ID: 27335383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors.
    Bramble MS; Hoff N; Gilchuk P; Mukadi P; Lu K; Doshi RH; Steffen I; Nicholson BP; Lipson A; Vashist N; Sinai C; Spencer D; Olinger G; Wemakoy EO; Illunga BK; Pettitt J; Logue J; Marchand J; Varughese J; Bennett RS; Jahrling P; Cavet G; Serafini T; Ollmann Saphire E; Vilain E; Muyembe-Tamfum JJ; Hensely LE; Simmons G; Crowe JE; Rimoin AW
    J Infect Dis; 2018 Nov; 218(12):1929-1936. PubMed ID: 30107445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors.
    Sobarzo A; Stonier SW; Radinsky O; Gelkop S; Kuehne AI; Edri A; Herbert AS; Fedida-Metula S; Lutwama JJ; Yavelsky V; Davis C; Porgador A; Dye JM; Lobel L
    EBioMedicine; 2019 Aug; 46():215-226. PubMed ID: 31326432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of human antibody-mediated neutralization of Marburg virus.
    Flyak AI; Ilinykh PA; Murin CD; Garron T; Shen X; Fusco ML; Hashiguchi T; Bornholdt ZA; Slaughter JC; Sapparapu G; Klages C; Ksiazek TG; Ward AB; Saphire EO; Bukreyev A; Crowe JE
    Cell; 2015 Feb; 160(5):893-903. PubMed ID: 25723164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.
    Warfield KL; Swenson DL; Negley DL; Schmaljohn AL; Aman MJ; Bavari S
    Vaccine; 2004 Sep; 22(25-26):3495-502. PubMed ID: 15308377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus Survivors.
    Sobarzo A; Stonier SW; Herbert AS; Ochayon DE; Kuehne AI; Eskira Y; Fedida-Metula S; Tali N; Lewis EC; Egesa M; Cose S; Lutwama JJ; Yavelsky V; Dye JM; Lobel L
    Viruses; 2016 May; 8(5):. PubMed ID: 27187443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study.
    Bockstal V; Shukarev G; McLean C; Goldstein N; Bart S; Gaddah A; Anumenden D; Stoop JN; Marit de Groot A; Pau MG; Hendriks J; De Rosa SC; Cohen KW; McElrath MJ; Callendret B; Luhn K; Douoguih M; Robinson C
    PLoS One; 2022; 17(10):e0274906. PubMed ID: 36197845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune memory to Sudan virus: comparison between two separate disease outbreaks.
    Sobarzo A; Eskira Y; Herbert AS; Kuehne AI; Stonier SW; Ochayon DE; Fedida-Metula S; Balinandi S; Kislev Y; Tali N; Lewis EC; Lutwama JJ; Dye JM; Yavelsky V; Lobel L
    Viruses; 2015 Jan; 7(1):37-51. PubMed ID: 25569078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine design.
    Khurana S; Grubbs G; Ravichandran S; Cluff E; Kim J; Kuehne AI; Zak S; Dye JM; Lutwama JJ; Herbert AS
    Nat Commun; 2024 Sep; 15(1):8133. PubMed ID: 39285186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
    Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
    J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein.
    Martins K; Carra JH; Cooper CL; Kwilas SA; Robinson CG; Shurtleff AC; Schokman RD; Kuehl KA; Wells JB; Steffens JT; van Tongeren SA; Hooper JW; Bavari S
    Viral Immunol; 2015 Feb; 28(1):62-70. PubMed ID: 25514232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marburg virus-like particles produced in insect cells induce neutralizing antibodies in rhesus macaques.
    Weiwei G; Xuexing Z; Chong W; Yongkun Z; Qi W; Hualei W; Gary W; Ying X; Haijun W; Zengguo C; Na F; Hang C; Tiecheng W; Yuwei G; Junjie S; Songtao Y; Xianzhu X
    J Med Virol; 2017 Dec; 89(12):2069-2074. PubMed ID: 28402024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease.
    Babirye P; Musubika C; Kirimunda S; Downing R; Lutwama JJ; Mbidde EK; Weyer J; Paweska JT; Joloba ML; Wayengera M
    BMC Infect Dis; 2018 Oct; 18(1):498. PubMed ID: 30285648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.
    Kuzmin IV; Schwarz TM; Ilinykh PA; Jordan I; Ksiazek TG; Sachidanandam R; Basler CF; Bukreyev A
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.
    Warfield KL; Olinger GG
    J Biomed Biotechnol; 2011; 2011():984241. PubMed ID: 22253531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictions.
    Bozhanova NG; Sangha AK; Sevy AM; Gilchuk P; Huang K; Nargi RS; Reidy JX; Trivette A; Carnahan RH; Bukreyev A; Crowe JE; Meiler J
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31142-31148. PubMed ID: 33229516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.